TP53 and glioma: The SNRPG-mediated inhibitory effect on glioma cells might have been due to the direct suppression of Myc as well as p53 and the ensuing modification of their downstream molecules, possibly promoting apoptosis and cell cycle arrest by interacting directly or indirectly with related proteins.